bioAffinity Technologies receives Australian patent acceptance

Go back to bioAffinity Technologies receives Australian patent acceptance

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

October 28, 2025 8:00 AM EDT

Australian patent strengthens global patent portfolio

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage diagnostics including... More